Recent research showed that the knockdown of NLRP3 could inhibit the growth and invasion of glioma cells (Xue et al. 2019), along with the decrease of IL-1β and NF-κB, indicating a positive correlation between NLRP3 and NF-κB. Here, IL1B is linked to central nervous system cancer.